Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06380088
Other study ID # VEM-DINOGMI-24
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2022
Est. completion date March 15, 2024

Study information

Verified date April 2024
Source Universita degli Studi di Genova
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study used a randomised crossover design to analyse the effect of three different experimental interventions - i.e. standard conditions, music and verbal encouragement - on performance in an isometric endurance task, comparing results between untrained and trained individuals. The interval between each intervention was set at seven days. The outcome measures are muscle activity and fatigue, assessed by surface electromyography, and task duration. Isometric endurance task requires participants to keep their arm flexed at a 90° angle while holding a dumbbell with a supine grip loaded to 80% of 1RM on the dominant side of the body. During execution, the back and head should remain in contact with a vertical wall, with the feet shoulder width apart and firmly planted on the floor. The bar is held with the dominant arm while the other arm remains in a neutral position close to the body. It is imperative to avoid any form of rocking or movement that would make it easier to maintain the position. The test officially begins when the bar is handed to the subject, who is already in the correct position, and ends as soon as the angle of the arm varies by more than five degrees from the starting position.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date March 15, 2024
Est. primary completion date August 5, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 27 Years to 40 Years
Eligibility Inclusion Criteria: To be included in the study, candidates had to be in good general health, with no medical conditions that could interfere with their ability to perform the test safely and effectively. In addition, to be considered trained, participants had to have performed 150 minutes per week of vigorous-intensity aerobic physical activity, in addition to muscle-strengthening activities, on at least two days per week. Those who did not meet this standard were considered untrained. - Exclusion Criteria: Exclusion criteria included a history of surgery to the arm, shoulder, or nearby areas that could limit the ability to perform the test. The use of medications that affect muscle function or pain perception was also a reason for exclusion, so that the test results could not be influenced by external factors. -

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Isometric Task
The exercise required participants to keep their arm flexed at a 90° angle while holding a dumbbell loaded to 80% of their 1RM (One Rep Max) in a supine position on the dominant side of the body for as long as possible.

Locations

Country Name City State
Italy Università degli Studi di Genova Genova

Sponsors (1)

Lead Sponsor Collaborator
Universita degli Studi di Genova

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of the task task duration expressed in seconds 60 seconds
Primary Biceps Brachii muscle fatigue time-course evolution of the median frequency of the power density spectrum (MF [Hz]) of the sEMG signal measured for Biceps Brachii muscle 60 seconds
Primary Triceps Brachii muscle fatigue time-course evolution of the median frequency of the power density spectrum (MF [Hz]) of the sEMG signal measured for Triceps Brachii muscle 60 seconds
Primary Biceps Brachii activity time-course evolution of the amplitude (Root Mean Square [microvolt]) of the sEMG signal measured for Biceps Brachii muscle 60 seconds
Primary Triceps Brachii activity time-course evolution of the amplitude (Root Mean Square [microvolt]) of the sEMG signal measured for Triceps Brachii muscle 60 seconds
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1